Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1736 participants.
Also called NCT01864174
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,736 participants
- Sponsor
- Registry
-
NCT01864174 -
2012-004531-23
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Czechia, Germany, Hungary, Poland, Puerto Rico, Romania, South Africa, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01864174. Randomized; double masking; primary purpose treatment. Start 2013-06-20 (actual); primary completion 2016-06-01 (actual). Results posted on 2017-07-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Metformin XR
- Intervention (Drug)
- Metformin IR
- Intervention (Drug)
- Placebo matching with Metformin XR
- Intervention (Drug)
- Placebo matching with Metformin IR
- Lead sponsor
- Bristol-Myers Squibb
Record details
- Record id
cardio:ct-nct01864174- Content hash
39db22bad55397f8890af2ec483d19df5926a58966dfe9335661e0ef85ecd790